HBC.OL
Strong SellSinkerHofseth BioCare ASA · Consumer Defensive · Norway · $77M · Avg Vol: $13K/d
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
3
StockRankGet insider-trade alerts
QualityQuality
16
ValueValue
24
MomentumMomentum
28
P/E (TTM)
—
peers 20.8x
ROE
—
peers -2.9%
D/E
—
peers 1.0x
Dividend %
—
trailing yield
ABOUT HOFSETH BIOCARE ASA
Read
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States.
FINANCIAL SUMMARY (NOK)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 120.4M | 194.9M | 257.4M | 256.3M | 28.6% | 242.2M |
| EPS (NOK) | -0.37 | -0.27 | -0.30 | -0.33 | — | -0.34 |
| Shares | 395.1M | 395.1M | 395.1M | 395.1M | 0.0% | 506.2M |
| Debt | 104.2M | 280.8M | 170.9M | 359.9M | 51.2% | 338.6M |
| Equity | 148.7M | 41.8M | 60.0M | -74.8M | -36.5% | — |
| Op CF | -45.2M | 2.8M | -11.4M | -27.8M | — | 2.0M |
| Inv CF | -17.8M | -15.0M | -4.1M | -20.5M | — | — |
| Fin CF | 45.5M | 3.7M | 17.2M | 91.5M | — | — |
Loading 1Y...
PRICE (1Y)-1.1%
SMA 50SMA 200
Close
$0.1379
RSI (14)
48.2
52W High
$0.2228
From 52W High
0.6%
SCORE BREAKDOWN
Quality
16
ROIC
-73.3%0.9
ROE
—N/A
GP/Assets
18.6%29.4
Op. Margin
-19.6%4.8
FCF/Assets
-12.8%4.5
Piotroski
528.2
Int. Cover
-4.3x5.1
D/E Ratio
—N/A
Current Ratio
0.85x14.8
Value
24
P/E (TTM)
—N/A
EV/EBITDA
-9.4x25.0
P/FCF
—N/A
P/B
-22.5x25.0
P/S
2.8x18.4
Div Yield
—N/A
Momentum
28
52W High %
62%20.4
RS 6M
—N/A
SMA 50/200
1.00x54.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$77M
P/E (Forward)
—
Gross Margin
30.5%
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of HBC.OL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HBC.OL | Hofseth BioCare ASA(you) | $77M | 3 | Strong Sell |
| DELIA.OL | Dellia Group ASA | $101M | 27 | Sell |
| AKBM.OL | Aker BioMarine ASA | $1.2B | 21 | Sell |
| LSG.OL | Lerøy Seafood Group ASA | $2.9B | 32 | Sell |
| NCOD.OL | Norcod AS | $111M | 3 | Strong Sell |
| GIGA.OL | Gigante Salmon AS | $123M | 2 | Strong Sell |
| SALME.OL | Salmon Evolution ASA | $231M | 3 | Strong Sell |
| ISLAX.OL | Icelandic Salmon AS | $192M | 9 | Strong Sell |
| NOHAL.OL | Nordic Halibut AS | $169M | 15 | Strong Sell |
| NOAP.OL | Nordic Aqua Partners A/S | $195M | 17 | Strong Sell |
Peer medians: ROE -2.9% · P/E 20.8x · Gross margin 46.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.